Companies
- Companies
- Browse
Companies
Affimed is a product-oriented biotech company with a strong position in monoclonal antibodies - the fastest growing segment of the pharmaceutical industry. More
A research driven point-of-care diagnostic company More
Roche Protein Expression Group provides access to high-value therapeutic targets and peptides! More
Using its unique technology, biopharmaceutical company, Aptagen develops targeted drugs and licenses out new drugs to global pharmaceutical companies. More
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
BayernPatent offers a wide range of high quality patents from Bavarian universities. More
Nanogenics Solutions is the exclusive licensee to the vector system (LipTide™) developed by University College London (UCL) for targeted delivery of DNA, RNA, peptides and drugs into cells. More
Amerson Ltd. is a US based China market focused pharmaceuticals and medical products consulting firm. Our primary interest is to in-license late stage and/or US/EU approved novel healthcare products More
Ghent University, a major European University with a strong focus on research More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Jan 2009 - $15,200
Nov 2011 - 8 pages - $75
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us